The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2026 | Incidence of driver mutations varies across never-smokers with lung cancer
Sindhu Naidu, MBBS, BSc (Hons), MRCP, FHEA, PGCert (Med Ed), University College London, London, UK, explores results from a study examining driver mutations in never-smokers, highlighting that female patients, younger patients and those with adenocarcinoma histology were more likely to have driver mutations. In addition, patients from less deprived areas and those of Asian or black ethnicities were similarly found to more commonly have driver mutations. This interview took place at the IASLC 2026 World Conference on Lung Cancer congress in Seoul, Republic of Korea.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
